PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Nanoscale1 citations

Multifunctional ruthenium-based complexes for chronic wound therapy: from ligand engineering to intelligent microenvironment remodeling

View Full Paper
YLYulong LanJSJianliang ShenLTLifeng Tan

Key Points

  • This review focuses on transforming ruthenium-based complexes into multifunctional therapeutic systems for chronic wounds.
  • Analyzed chronic wound microenvironment to identify therapeutic targets
  • Detailed properties of ruthenium-based nanomaterials and complexes
  • Outlined ligand design principles
  • Explored advanced design strategies for responsive drug release and targeted delivery
  • Investigated integrating diagnostics with therapy for feedback systems.
  • Identified key challenges such as biosafety and in vivo efficacy
  • Highlighted the multifunctional nature of ruthenium-based complexes
  • Emphasized the need for intelligent ligand engineering in chronic wound therapy

Abstract

Chronic wounds form a self-perpetuating vicious cycle driven by oxidative stress, immune dysregulation, and biofilm infections. Traditional monotherapies yield limited efficacy, posing significant clinical challenges. Ruthenium-based complexes (RuBCs), as an emerging therapeutic platform, offer breakthrough opportunities in this field due to their inherent multi-enzyme mimetic activity, superior photophysical properties, and high tunability achieved through ligand engineering. This review systematically elucidates how intelligent ligand design transforms ruthenium-based biomaterials from passive drugs into smart diagnostic-therapeutic integrated systems capable of sensing and responding to pathological wound microenvironments (such as abnormal pH, elevated reactive oxygen species, and specific enzymes). Initially, we analyze the chronic wound microenvironment to establish precise therapeutic targets. We subsequently detail the fundamental properties of ruthenium-based nanomaterials and complexes, along with ligand design principles, to construct a multifunctional toolkit. The core section systematically integrates multiple advanced design strategies, including environmentally responsive drug release, targeted cellular or bacterial delivery, and the synergistic integration of catalytic, phototherapeutic, and immunomodulatory functions. Furthermore, we explore how to combine real-time phosphorescence diagnostics with therapy to establish closed-loop feedback systems. Despite promising prospects, RuBCs still face significant challenges such as long-term biosafety, large-scale preparation, and in vivo efficacy validation. The conclusion outlines future directions: developing multi-stimulus-responsive systems, synergizing with advanced biomaterials, and leveraging AI-assisted design. These efforts aim to provide systematic, forward-looking theoretical and technical guidance for developing smart RuBCs for chronic wound treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lan et al. (2026) studied this question.

synapsesocial.com/papers/69b4ad7918185d8a39800c0ahttps://doi.org/10.1039/d5nr05441a
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lattice expansion in ruthenium nanozymes improves catalytic activity and electro-responsiveness for boosting cancer therapy2024 · 65 citations
  2. 2Targeted Ruthenium‐Based Anti‐Inflammatory Nanoagent for Enhanced Rheumatoid Arthritis Treatment2025 · 16 citations
  3. 3Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy2024 · 59 citations
  4. 4Molecular Steric Engineering of Ir(III) Complexes Enables Color‐Pure and Efficient NonDoped Deep‐Blue Organic Light‐Emitting Diodes2025 · 4 citations
  5. 5The ruthenium complex assists in nuclear targeting and selective killing of tumor cells2023 · 11 citations